Magdalena Skonieczna

34PUBLICATIONS
60CO-AUTHORS
Molecular targetsWearable materialsCancer geneticsCheminformatics and quantitative structure-activity relationshipsFood engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Aug 27, 2026
Novel Triazole-Diquinothiazine Hybrids Modulating Apoptosis and Stress Pathways in Colorectal Cancer Cells.

|Aug 20, 2026
Winning the 'race for the surface': curcumin-loaded PEDOT coatings with enhanced biocompatibility and antibacterial capabilities.

|Jun 26, 2026
Quinobenzothiazine-AZT Hybrids Linked via 1,2,3-Triazole: Rational Design, Synthesis, and Biological Evaluation as Anticancer Agents.

|Nov 27, 2025
CRISPR Genome Editing in Personalized Therapy for Oral and Maxillofacial Diseases: A Scoping Review.

Arkadiusz Dziedzic, Robert Kubina, Magdalena Skonieczna

|Jul 29, 2025
Design, Synthesis, and Testing of 1,2,3-Triazolo-Quinobenzothiazine Hybrids for Cytotoxic and Immunomodulatory Activity.

Klaudia Giercuszkiewicz-Haśnik, Magdalena Skonieczna, Beata Morak-Młodawska

|Feb 26, 2025
Correction: Maksymowicz et al. The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan. Pharmaceuticals 2022, 15, 732.

Jerzy Maksymowicz, Anna Palko-Łabuz, Beata Sobieszczańska

Pageof 6

Frequent Collaborators

5 joint publications

Kamila Środa-Pomianek

5 joint publications

Anna Kasprzycka

5 joint publications

Olga Wesołowska

5 joint publications

Beata Morak-Młodawska